SCHEMBL2464477

SCHEMBL2464477

CCOC(=O)c1ccc(-n2cnc(C)c2)c(OC)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.44
PSEN1 P49768 10/20 0.43
PSEN2 P49810 10/20 0.43
APH1B Q8WW43 10/20 0.43
NCSTN Q92542 10/20 0.43
APH1A Q96BI3 10/20 0.43
PSENEN Q9NZ42 10/20 0.43
KCNH2 Q12809 2/20 0.43
NOTUM Q6P988 1/20 0.43
GABRA2 P47869 4/20 0.41
GABRB2 P47870 4/20 0.41
KDM4E B2RXH2 2/20 0.41
POLB P06746 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
APP P05067 2/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9224077 0.89 MEN1 (0.51) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL12958099 0.88 NOTUM (0.46) CYP1A2NOTUMGABRA2GABRB2
SCHEMBL18527107 0.85 PSEN1 (0.41) CYP1A2PSEN1PSEN2APH1BNCSTN
SCHEMBL254304 0.85 PSEN1 (0.41) CYP1A2PSEN1PSEN2APH1BNCSTN
SCHEMBL194967 0.85 PSEN1 (0.46) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL194790 0.85 PSEN1 (0.43) PSEN1PSEN2APH1BNCSTNAPH1A
Hydrochloric Acid SCHEMBL18527218 0.84 PSEN1 (0.41) CYP1A2PSEN1PSEN2APH1BNCSTN
Hydrochloric Acid SCHEMBL18527101 0.84 PSEN1 (0.41) CYP1A2PSEN1PSEN2APH1BNCSTN
SCHEMBL1672369 0.84 PSEN1 (0.47) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL155825 0.83 P2RX7 (0.46) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809318-B2 Gamma secretase modulators MERCK SHARP & DOHME CORP. (US) 2014-08-19 US disclosed
US-8809318-B2 Gamma secretase modulators MERCK SHARP & DOHME CORP. (US) 2014-08-19 US disclosed
US-20110306593-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME LLC 2011-12-15 US disclosed
US-20110306593-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME LLC 2011-12-15 US disclosed
EP-2365973-A1 GAMMA SECRETASE MODULATORS Schering Corporation (US) 2011-09-21 EP disclosed
WO-2010056722-A1 GAMMA SECRETASE MODULATORS SCHERING CORPORATION (US) 2010-05-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306593-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, PSEN1 CYP1A2 3420/4885PSEN1 3/4885PSEN2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.